These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31489120)

  • 1. Correction: Calcium electroporation for treatment of sarcoma in preclinical studies.
    Szewczyk A; Gehl J; Daczewska M; Saczko J; Frandsen SK; Kulbacka J
    Oncotarget; 2019 Aug; 10(49):5118. PubMed ID: 31489120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium electroporation for treatment of sarcoma in preclinical studies.
    Szewczyk A; Gehl J; Daczewska M; Saczko J; Frandsen SK; Kulbacka J
    Oncotarget; 2018 Feb; 9(14):11604-11618. PubMed ID: 29545923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.
    Ohmoto A; Suzuki M; Takai E; Rokutan H; Fujiwara Y; Morizane C; Yanagihara K; Shibata T; Yachida S
    Oncotarget; 2019 Sep; 10(52):5494. PubMed ID: 31534635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts.
    Yang L; Forker L; Irlam JJ; Pillay N; Choudhury A; West CML
    Oncotarget; 2019 Mar; 10(20):2007. PubMed ID: 30956781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma.
    Zhu J; Wang M; Yu Y; Qi H; Han K; Tang J; Zhang Z; Zeng Y; Cao B; Qiao C; Zhang H; Hou T; Mao X
    Oncotarget; 2019 Dec; 10(65):7010-7011. PubMed ID: 31857854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
    Chung S; Kijima K; Kudo A; Fujisawa Y; Harada Y; Taira A; Takamatsu N; Miyamoto T; Matsuo Y; Nakamura Y
    Oncotarget; 2020 Oct; 11(41):3749-3750. PubMed ID: 33110482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.
    Kim S; Tiedt R; Loo A; Horn T; Delach S; Kovats S; Haas K; Engstler BS; Cao A; Pinzon-Ortiz M; Mulford I; Acker MG; Chopra R; Brain C; Tomaso ED; Sellers WR; Caponigro G
    Oncotarget; 2020 Apr; 11(14):1289. PubMed ID: 32292577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
    Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
    Oncotarget; 2018 Jul; 9(56):30937. PubMed ID: 30112120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
    Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
    Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
    Kawano S; Grassian AR; Tsuda M; Knutson SK; Warholic NM; Kuznetsov G; Xu S; Xiao Y; Pollock RM; Smith JJ; Kuntz KW; Ribich S; Minoshima Y; Matsui J; Copeland RA; Tanaka S; Keilhack H
    PLoS One; 2017; 12(1):e0170539. PubMed ID: 28085948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Post-pancreaticoduodenectomy hemorrhage: DSA diagnosis and endovascular treatment.
    Zhou TY; Sun JH; Zhang YL; Zhou GH; Nie CH; Zhu TY; Chen SQ; Wang BQ; Wang WL; Zheng SS
    Oncotarget; 2018 Mar; 9(20):15436. PubMed ID: 29634045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma.
    Pagès G
    Oncotarget; 2018 Nov; 9(87):35796. PubMed ID: 30515272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.
    Ladju RB; Pascut D; Massi MN; Tiribelli C; Sukowati CHC
    Oncotarget; 2018 Feb; 9(16):13101. PubMed ID: 29569656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: The role of substance P in epilepsy and seizure disorders.
    Wang XF; Ge TT; Fan J; Yang W; Li B; Cui RJ
    Oncotarget; 2019 May; 10(37):3576. PubMed ID: 31191827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer.
    Phan ANH; Vo VTA; Hua TNM; Kim MK; Jo SY; Choi JW; Kim HW; Son J; Suh YA; Jeong Y
    Oncotarget; 2019 Feb; 10(14):1473. PubMed ID: 30858930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Incidence and risk of regorafenib-induced hepatotoxicity.
    Zhao B; Zhao H
    Oncotarget; 2019 Jan; 10(2):253. PubMed ID: 30719219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Molecular response prediction in CML: novel ideas?
    Wolf D; Sopper S
    Oncotarget; 2018 Nov; 9(88):35871. PubMed ID: 30533202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: p53 and metabolism: from mechanism to therapeutics.
    Simabuco FM; Morale MG; Pavan ICB; Morelli AP; Silva FR; Tamura RE
    Oncotarget; 2018 Sep; 9(74):34030. PubMed ID: 30338044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Genetically enhanced T lymphocytes and the intensive care unit.
    Tat T; Li H; Constantinescu CS; Onaciu A; Chira S; Osan C; Pasca S; Petrushev B; Moisoiu V; Micu WT; Berce C; Tranca S; Dima D; Berindan-Neagoe I; Shen J; Tomuleasa C; Qian L
    Oncotarget; 2018 Aug; 9(62):32097. PubMed ID: 30174800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.
    Hu J; Song C; Duan B; Zhang X; Li D; Zhu L; Gao H
    Oncotarget; 2018 Jul; 9(58):31311. PubMed ID: 30131857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.